Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or
申请人:Novo Nordisk A/S
公开号:US06080754A1
公开(公告)日:2000-06-27
The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
The ringtransformation of dinitropyridone afforded various kinds of 2,6-disubstituted-4-nitroanilines upon treatment with aliphatic ketones in the presence of ammonium acetate as a nitrogen source, wherein dinitropyridone behaved as the synthetic equivalent of unstable nitromalonaldehyde. The benzene ring, as well as the amino group of the nitroaniline framework, was easily modified by only changing
Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives
作者:Anker Steen Jørgensen、Poul Jacobsen、Lise Brown Christiansen、Paul S. Bury、Anders Kanstrup、Susan M. Thorpe、Lars Nærum、Karsten Wassermann
DOI:10.1016/s0960-894x(00)00474-1
日期:2000.10
A series of pyrrolo[2,1,5-cd]indolizinederivatives has been synthesized and evaluated as ligands for the estrogen receptor. Properly substituted mono- and di-hydroxy derivatives showed binding in the low nanomolar range in accordance with their structural resemblance to estrogen.